S026-0979 Screening compound: 3'-(cyclopentylamino)-N-(3,5-difluorophenyl)-1'H-spiro[piperidine-3,2'-pyrido[2,3-b]pyrazine]-1-carboxamide

S026-0979 Screening compound: 3'-(cyclopentylamino)-N-(3,5-difluorophenyl)-1'H-spiro[piperidine-3,2'-pyrido[2,3-b]pyrazine]-1-carboxamide
S026-0979 Screening compound: 3'-(cyclopentylamino)-N-(3,5-difluorophenyl)-1'H-spiro[piperidine-3,2'-pyrido[2,3-b]pyrazine]-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S026-0979
3'-(cyclopentylamino)-N-(3,5-difluorophenyl)-1'H-spiro[piperidine-3,2'-pyrido[2,3-b]pyrazine]-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S026-0979

Molecular Formula

C23H26F2N6O (C23 H26 F2 N6 O)

Compound Name

3'-(cyclopentylamino)-N-(3,5-difluorophenyl)-1'H-spiro[piperidine-3,2'-pyrido[2,3-b]pyrazine]-1-carboxamide

IUPAC name

3'-(cyclopentylamino)-N-(35-difluorophenyl)-1'H-spiro[piperidine-32'-pyrido[23-b]pyrazine]-1-carboxamide

SMILES

O=C(Nc1cc(F)cc(F)c1)N(CCC1)CC11Nc(cccn2)c2N=C1NC1CCCC1

InChI

InChI=1S/C23H26F2N6O/c24-15-11-16(25)13-18(12-15)28-22(32)31-10-4-8-23(14-31)21(27-17-5-1-2-6-17)29-20-19(30-23)7-3-9-26-20/h3,7,9,11-13,17,30H,1-2,4-6,8,10,14H2,(H,28,32)(H,26,27,29)/t23-/m0/s1

InChI Key

ZGNZBCJOLZOSGE-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD27616973

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

440.5

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.898

Distribution Coefficient, logD

2.735

Water Solubility, LogSw

-3.92

Polar Surface Area

67.154

Acid Dissociation Constant (pKa)

10.17

Base Dissociation Constant (pKb)

8.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

43.50

S026-0979 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

TLR-8 ligands Library (674 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Female
  • Skin
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
  • Cyclic compounds
Targets:
  • Others
Agro:
  • Agro

References: we are preparing a list of scientific research reports with S026-0979 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S026-0979?
Check Price and Availability of S026-0979, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S026-0979 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S026-0979
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S026-0979
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S026-0979 available by request